{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:34:21Z","timestamp":1781073261959,"version":"3.54.1"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["ZIA DA000389"],"award-info":[{"award-number":["ZIA DA000389"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Intramural Research Program","award":["ZIA DA000611"],"award-info":[{"award-number":["ZIA DA000611"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.neuropharm.2018.11.034","type":"journal-article","created":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T11:02:46Z","timestamp":1543057366000},"page":"107446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Pharmacological classification of centrally acting drugs using EEG in freely moving rats: an old tool to identify new atypical dopamine uptake inhibitors"],"prefix":"10.1016","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5043-8033","authenticated-orcid":false,"given":"Claudio","family":"Zanettini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Scaglione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline D.","family":"Keighron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoLynn B.","family":"Giancola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3693-5476","authenticated-orcid":false,"given":"Shih-Chieh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-9474","authenticated-orcid":false,"given":"Amy H.","family":"Newman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Tanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.11.034_bib1","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1021\/jm970525a","article-title":"Novel N-substituted 3 alpha-[bis(4\u2019-fluorophenyl)methoxy]tropane analogues: selective ligands for the dopamine transporter","volume":"40","author":"Agoston","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib2","first-page":"362","article-title":"Cortical EEG oscillations and network connectivity as efficacy indices for assessing drugs with cognition enhancing potential","volume":"86","author":"Ahnaou","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib3","author":"Allaire"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0893-133X(97)00211-X","article-title":"Persistent QEEG abnormality in crack cocaine users at 6 months of drug abstinence","volume":"19","author":"Alper","year":"1998","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.drugalcdep.2011.07.007","article-title":"Modafinil for the treatment of methamphetamine dependence","volume":"120","author":"Anderson","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.drugalcdep.2009.04.015","article-title":"Modafinil for the treatment of cocaine dependence","volume":"104","author":"Anderson","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib7","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1093\/sleep\/17.suppl_8.S107","article-title":"Modafinil: a double-blind multicentric study","volume":"17","author":"Billiard","year":"1994","journal-title":"Sleep"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib8","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1021\/ml1002025","article-title":"Structure-activity relationships at the monoamine transporters for a novel series of modafinil (2-[(diphenylmethyl)sulfinyl]acetamide) analogues","volume":"2","author":"Cao","year":"2010","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib9","series-title":"Neurotransmitter Transporters, Contemporary Neuroscience","first-page":"381","article-title":"Dopamine-transporter uptake blockers","author":"Carroll","year":"2002"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsat.2011.12.014","article-title":"A double-blind, placebo-controlled trial of modafinil for cocaine dependence","volume":"43","author":"Dackis","year":"2012","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib11","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00213-002-1080-8","article-title":"Study of the addictive potential of modafinil in naive and cocaine-experienced rats","volume":"161","author":"Deroche-Gamonet","year":"2002","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1124\/jpet.113.208538","article-title":"Pharmacological characterization of a dopamine transporter ligand that functions as a cocaine antagonist","volume":"348","author":"Desai","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib13","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1523\/JNEUROSCI.4778-04.2005","article-title":"Identification of a dopamine transporter ligand that blocks the stimulant effects of cocaine","volume":"25","author":"Desai","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib14","first-page":"626","article-title":"Cognition-Enhancing doses of methylphenidate preferentially increase prefrontal cortex neuronal responsiveness","author":"Devilbiss","year":"2008","journal-title":"Biological Psychiatry, Endophenotypes for Autism Spectrum Disorder and Attention-Deficit\/Hyperactivity Disorder 64"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib15","doi-asserted-by":"crossref","first-page":"5274","DOI":"10.1073\/pnas.85.14.5274","article-title":"Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats","volume":"85","author":"Di Chiara","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"5","key":"10.1016\/j.neuropharm.2018.11.034_bib16","first-page":"199","article-title":"Preclinical data base of pharmaco-specific rat EEG fingerprints (tele-stereo-EEG)","volume":"8","author":"Dimpfel","year":"2003","journal-title":"Eur. J. Med. Res."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF02244852","article-title":"Studies on electroencephalogram (EEG) in rats suggest that moderate doses of cocaine ord-amphetamine activate D1 rather than D2 receptors","volume":"114","author":"Ferger","year":"1994","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/BF02245188","article-title":"Effects of morphine on EEG in rats and their possible relations to hypo- and hyperkinesia","volume":"117","author":"Ferger","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00169174","article-title":"Effects of cocaine on the EEG power spectrum of rats are significantly altered after its repeated administration: do they reflect sensitization phenomena?","volume":"353","author":"Ferger","year":"1996","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib20","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0447.2009.01467.x","article-title":"Remembering the lost neuroscience of pharmaco-EEG","volume":"121","author":"Fink","year":"2010","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0364-7722(80)90019-3","article-title":"An objective classification of psychoactive drugs","volume":"4","author":"Fink","year":"1980","journal-title":"Prog. Neuro Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib22","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.pa.09.040169.001325","article-title":"EEG and human psychopharmacology","volume":"9","author":"Fink","year":"1969","journal-title":"Annu. Rev. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1159\/000117957","article-title":"EEG evaluation of drug effects in the rat","volume":"9","author":"Glatt","year":"1983","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib24","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/BF02247379","article-title":"Evaluation of the cocaine-like discriminative stimulus effects and reinforcing effects of modafinil","volume":"126","author":"Gold","year":"1996","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib25","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.addbeh.2004.06.018","article-title":"Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence","volume":"29","author":"Grabowski","year":"2004","journal-title":"Addict. Behav."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib26","doi-asserted-by":"crossref","first-page":"e6755","DOI":"10.1371\/journal.pone.0006755","article-title":"NMDA receptor hypofunction leads to generalized and persistent aberrant gamma oscillations independent of hyperlocomotion and the state of consciousness","volume":"4","author":"Hakami","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/sj.npp.1301472","article-title":"Smoked cocaine self-administration is decreased by modafinil","volume":"33","author":"Hart","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib28","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.neuropharm.2013.05.021","article-title":"A preclinical evaluation of the discriminative and reinforcing properties of lisdexamfetamine in comparison to d-amfetamine, methylphenidate and modafinil","volume":"73","author":"Heal","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF02244069","article-title":"Awakening properties of modafinil: effect on nocturnal activity in monkeys (Macaca mulatta) after acute and repeated administration","volume":"103","author":"Hermant","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/npp.1994.30","article-title":"Cocaine-induced increases in EEG alpha and beta activity: evidence for reduced cortical processing","volume":"11","author":"Herning","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib31","article-title":"Differential roles for dopamine D1-like and D2-like receptors in mediating the reinforcing effects of cocaine: convergent evidence from pharmacological and genetic studies","volume":"3","author":"Hiranita","year":"2015","journal-title":"J Alcohol Drug Depend"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/jpet.113.208264","article-title":"Preclinical efficacy of N-substituted benztropine analogs as antagonists of methamphetamine self-administration in rats","volume":"348","author":"Hiranita","year":"2014","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.108.145813","article-title":"Assessment of reinforcing effects of benztropine analogs and their effects on cocaine self-administration in rats: comparisons with monoamine uptake inhibitors","volume":"329","author":"Hiranita","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib34","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/bimj.200810425","article-title":"Simultaneous inference in general parametric models","volume":"50","author":"Hothorn","year":"2008","journal-title":"Biom. J."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib35","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-12-420118-7.00004-4","article-title":"Monoamine transporter inhibitors and substrates as treatments for stimulant abuse","volume":"69","author":"Howell","year":"2014","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib36","first-page":"395","article-title":"Clinical and EEG effects of GB-94, a \u201ctetracyclic\u201d antidepressant (EEG model in discovery of a new psychotropic drug)","volume":"14","author":"Itil","year":"1972","journal-title":"Curr. Ther. Res. Clin. Exp."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib37","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/026988110001400107","article-title":"An evaluation of the abuse potential of modafinil using methylphenidate as a reference","volume":"14","author":"Jasinski","year":"2000","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00002826-200005000-00004","article-title":"Evaluation of the abuse liability of modafinil and other drugs for excessive daytime sleepiness associated with narcolepsy","volume":"23","author":"Jasinski","year":"2000","journal-title":"Clin. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib39","series-title":"SciPy: Open Source Scientific Tools for Python","author":"Jones","year":"2001"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib40","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1017\/S1461145711000848","article-title":"Acute administration of typical and atypical antipsychotics reduces EEG \u03b3 power, but only the preclinical compound LY379268 reduces the ketamine-induced rise in \u03b3 power","volume":"15","author":"Jones","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib41","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.drugalcdep.2015.08.005","article-title":"A double blind, placebo controlled trial of modafinil for the treatment of cocaine dependence without co-morbid alcohol dependence","volume":"155","author":"Kampman","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib42","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.biopsych.2014.03.031","article-title":"Preference for distinct functional conformations of the dopamine transporter alters the relationship between subjective effects of cocaine and stimulation of mesolimbic dopamine","volume":"76","author":"Kohut","year":"2014","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib1a","article-title":"Distinct effects of (R)-modafinil and its (R)- and (S)-fluoro-analogs on mesolimbic extracellular dopamine assessed by voltammetry and microdialysis in rats","author":"Keighron","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000118392","article-title":"Classification of psychotropic drugs by rat EEG analysis: the anxiolytic profile in comparison to the antidepressant and neuroleptic profile","volume":"18","author":"Krijzer","year":"1987","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib44","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/FBP.0000000000000288","article-title":"Oral modafinil facilitates intracranial self-stimulation in rats: comparison with methylphenidate","volume":"28","author":"Lazenka","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib45","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.bcp.2010.10.002","article-title":"Aligning strategies for using EEG as a surrogate biomarker: a review of preclinical and clinical research","volume":"81","author":"Leiser","year":"2011","journal-title":"Biochemical Pharmacology, Translational Medicine"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00213-012-2862-2","article-title":"The stereotypy-inducing effects of N-substituted benztropine analogs alone and in combination with cocaine do not account for their blockade of cocaine self-administration","volume":"225","author":"Li","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib47","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biopsych.2012.03.022","article-title":"R-modafinil (armodafinil): a unique dopamine uptake inhibitor and potential medication for psychostimulant abuse","volume":"72","author":"Loland","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib48","first-page":"146","article-title":"Behavioral and EEG studies of acute cocaine administration: comparisons with morphine, amphetamine, pentobarbital, nicotine, ethanol and marijuana","volume":"95","author":"Lukas","year":"1989","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib49","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0022-3565(25)32982-4","article-title":"Differential electroencephalographic and behavioral cross tolerance to morphine and methadone in the l-alpha-acetylmethadol (LAAM)-maintained rat","volume":"220","author":"Lukas","year":"1982","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib50","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/S0022-3565(25)32309-8","article-title":"Comparative study of the electroencephalographic and behavioral effects of l-alpha-acetylmethadol (LAAM), two of its metabolites and morphine and methadone in the rat","volume":"215","author":"Lukas","year":"1980","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib51","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/syn.890160104","article-title":"Power spectral analysis of electroencephalographic desynchronization induced by cocaine in rats: correlation with microdialysis evaluation of dopaminergic neurotransmission at the medial prefrontal cortex","volume":"16","author":"Luoh","year":"1994","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib52","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1124\/jpet.115.231712","article-title":"Discovery and characterization of AMPA receptor modulators selective for TARP-\u03b38","volume":"357","author":"Maher","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib53","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s00213-013-3232-4","article-title":"The neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders","volume":"229","author":"Mereu","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib54","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/ejn.13376","article-title":"The unique psychostimulant profile of (\u00b1)-modafinil: investigation of behavioral and neurochemical effects in mice","volume":"45","author":"Mereu","year":"2017","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib55","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1080\/10401230490453743","article-title":"Modafinil: preclinical, clinical, and post-marketing surveillance--a review of abuse liability issues","volume":"16","author":"Myrick","year":"2004","journal-title":"Ann. Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib56","series-title":"Fmsb: Functions for Medical Statistics Book with Some Demographic Data","author":"Nakazawa","year":"2018"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib57","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1037\/a0021042","article-title":"Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys","volume":"18","author":"Newman","year":"2010","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib58","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S1388-2457(02)00409-1","article-title":"Quantitative EEG abnormalities in recently abstinent methamphetamine dependent individuals","volume":"114","author":"Newton","year":"2003","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib59","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.pbb.2010.03.006","article-title":"Psychostimulant-like discriminative stimulus and locomotor sensitization properties of the wake-promoting agent modafinil in rodents","volume":"95","author":"Paterson","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib60","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.biopsych.2007.10.006","article-title":"N-methyl d-aspartate receptor antagonists ketamine and MK-801 induce wake-related aberrant gamma oscillations in the rat neocortex","volume":"63","author":"Pinault","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib61","series-title":"Nlme: Linear and Nonlinear Mixed Effects Models","author":"Pinheiro","year":"2018"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib62","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.pbb.2013.07.011","article-title":"Combined effects of modafinil and d-amphetamine in male Sprague-Dawley rats trained to discriminate d-amphetamine","volume":"110","author":"Quisenberry","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib63","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/sj.npp.1300888","article-title":"Topographic imaging of quantitative EEG in response to smoked cocaine self-administration in humans","volume":"31","author":"Reid","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2014.12.005","article-title":"Behavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporter","volume":"147","author":"Reith","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib65","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","article-title":"Cocaine receptors on dopamine transporters are related to self-administration of cocaine","volume":"237","author":"Ritz","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib66","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.drugalcdep.2013.12.015","article-title":"A two-phased screening paradigm for evaluating candidate medications for cocaine cessation or relapse prevention: modafinil, levodopa-carbidopa, naltrexone","volume":"136","author":"Schmitz","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib67","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/sj.bjp.0702894","article-title":"Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission","volume":"128","author":"Sebban","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib68","first-page":"14","article-title":"Clinical and EEG studies of doxepin. An interim report","volume":"10","author":"Simeon","year":"1969","journal-title":"Psychosomatics"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib69","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/PL00005059","article-title":"Sensitization to d-amphetamine after its repeated administration: evidence in EEG and behaviour","volume":"356","author":"Stahl","year":"1997","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib70","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s00213-005-0044-1","article-title":"Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration","volume":"182","author":"Stoops","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib71","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S1054-3589(08)57007-4","article-title":"Discovery of drugs to treat cocaine dependence: behavioral and neurochemical effects of atypical dopamine transport inhibitors","volume":"57","author":"Tanda","year":"2009","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib72","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.drugalcdep.2009.09.002","article-title":"Modafinil does not serve as a reinforcer in cocaine abusers","volume":"106","author":"Vosburg","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib73","author":"Wickham"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib74","series-title":"Drug Discovery and Development","first-page":"199","article-title":"EEG, EEG power spectra, and behavioral correlates of opioids and other psychoactive agents","author":"Young","year":"1987"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib75","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00213-017-4739-x","article-title":"Behavioral economic analysis of the effects of N-substituted benztropine analogs on cocaine self-administration in rats","volume":"235","author":"Zanettini","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.11.034_bib76","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1124\/jpet.108.146142","article-title":"Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil","volume":"329","author":"Zolkowska","year":"2009","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2018.11.034_bib77","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.brainres.2006.11.099","article-title":"A comparison between spontaneous electroencephalographic activities induced by morphine and morphine-related environment in rats","volume":"1136","author":"Zuo","year":"2007","journal-title":"Brain Res."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081830875X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002839081830875X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:58:31Z","timestamp":1758437911000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002839081830875X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":78,"alternative-id":["S002839081830875X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.11.034","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological classification of centrally acting drugs using EEG in freely moving rats: an old tool to identify new atypical dopamine uptake inhibitors","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.11.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"107446"}}